Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
(Values in U.S. thousands)
| 05-2026 | 02-2026 | 11-2025 | 08-2025 | 05-2025 | |
| Sales | 9,043 | 6,252 | 13,577 | 7,894 | 44,056 |
| Gross Profit | 9,043 | 6,252 | 13,577 | 7,894 | 44,056 |
| Operating Expenses | 103,247 | 98,747 | 96,672 | 99,279 | 92,378 |
| Operating Income | -94,204 | -92,495 | -83,095 | -91,385 | -48,322 |
| Other Income | 4,398 | 5,321 | 4,874 | 4,964 | 5,618 |
| Pre-tax Income | -89,806 | -87,174 | -78,221 | -86,421 | -42,704 |
| Income Tax | -271 | N/A | N/A | 0 | 760 |
| Net Income Continuous | -89,535 | -87,174 | -78,221 | -86,421 | -43,464 |
| Net Income | $-89,535 | $-87,174 | $-78,221 | $-86,421 | $-43,464 |
| EPS Basic Total Ops | -0.81 | -0.79 | -0.83 | -1.03 | -0.52 |
| EPS Basic Continuous Ops | -0.81 | -0.79 | -0.83 | -1.03 | -0.52 |
| EPS Diluted Total Ops | -0.81 | -0.79 | -0.83 | -1.03 | -0.52 |
| EPS Diluted Continuous Ops | -0.81 | -0.79 | -0.83 | -1.03 | -0.52 |
| EPS Diluted Before Non-Recurring Items | -0.81 | -0.79 | -0.82 | -1.03 | -0.52 |
| EBITDA(a) | $-90,354 | $-88,719 | $-88,786 | $-86,385 | $-43,225 |